European Union

EPO Patent Publication: Bioengineered Bacteria for Biofilm Curation

The European Patent Office has published a new patent application, EP2026030202A1, concerning the use of bioengineered bacteria for curating biofilms. The publication date is March 18, 2026, and it covers various International Patent Classifications related to medical treatments and biotechnology.

EPO Patent Application: Cardiomyocyte Delivery Platforms

The European Patent Office has published patent application EP2026030210A1 concerning cardiomyocyte delivery platforms and methods of use. The application was published on March 18, 2026, and lists various IPC classifications related to pharmaceutical compositions and biotechnology.

EPO Patent Bulletin: Method for Imparting Environmental Stress Resistance to Plants

The European Patent Office (EPO) has published a patent bulletin regarding a method for imparting environmental stress resistance to plants. The publication, EP2026029086A1, is dated March 18, 2026, and lists the International Patent Classification codes related to plant biotechnology and cultivation.

Klotho mRNA Patent EP4711452A2 Published

The European Patent Office published patent application EP4711452A2 on March 18, 2026, related to Klotho messenger-RNA (mRNA) technology. The patent application was filed by ADvantage Therapeutics, Inc. and details specific compositions and sequences for Klotho polypeptides.

Therapeutic Agent Delivery Methods via Ultrasound Patent Application

The European Patent Office has published patent application EP2026030486A1 concerning methods and compositions for delivering therapeutic agents via ultrasound. The publication date is March 18, 2026, and it covers various IPC classifications related to biotechnology and drug delivery.

Glutamic Acid Decarboxylase Patent Publication EP2026028978A1

The European Patent Office (EPO) has published patent application EP2026028978A1 concerning Glutamic Acid Decarboxylase and its applications. The publication date is March 18, 2026. The application is classified under various International Patent Classification (IPC) codes related to biotechnology and food science.

EPO Patent: Novel Double-Stranded RNA Sequence and Use

The European Patent Office has published a patent application (EP2026028973A1) for a novel double-stranded RNA sequence based on L-PGDS RNA and its use. The publication date is March 18, 2026, and it covers various designated states within Europe. The inventors have not yet been designated.

EPO Patent Publication: Vaccine Antigens and Use Thereof

The European Patent Office (EPO) has published patent application EP2026030201A2 concerning vaccine antigens and their use. The publication date is March 18, 2026. The inventors have not yet filed their designation.

EPO Patent Publication EP2026029176A1: Anti-Integrin α8β1 Antibody

The European Patent Office (EPO) has published patent application EP2026029176A1 concerning an anti-integrin α8β1 antibody. The publication date is March 18, 2026, and the inventors have not yet been designated.

EPO Patent EP2026030634A2: Sustained Transgene Expression Fusion Polypeptides

The European Patent Office has published patent application EP2026030634A2 concerning sustained transgene expression fusion polypeptides. The application details specific fusion polypeptides and their uses, with inventors not yet designated.